研究发现,TasP和PREP将不列颠哥伦比亚省艾滋病毒/艾滋病死亡率和新感染人数减少了90%以上,而加拿大在2022年新诊断的艾滋病毒病例增加了24.9%。 Study finds TasP and PrEP reduce BC HIV/AIDS deaths and new infections by over 90%, while Canada experiences a 24.9% increase in new HIV diagnoses in 2022.

根据不列颠哥伦比亚艾滋病毒/艾滋病英才中心的一项研究,将治疗作为预防(TasP)和接触前预防(PrEP)相结合的双管齐下的办法可以将艾滋病毒/艾滋病相关死亡和新感染减少90%以上。 A two-pronged approach combining Treatment as Prevention (TasP) and Pre-Exposure Prophylaxis (PrEP) can reduce HIV/AIDS-related deaths and new infections by over 90%, according to a study by the BC Centre for Excellence in HIV/AIDS. 自1996年以来,在不列颠哥伦比亚省,执行《国家防治艾滋病计划》和有针对性的PREP战略使艾滋病毒/艾滋病相关死亡率降低了95%,艾滋病毒新感染减少了91%。 Implementing TasP and targeted PrEP strategies has reduced HIV/AIDS-related mortality by 95% and HIV new infections by 91% in British Columbia since 1996. 尽管如此,加拿大在2022年和2021年新增艾滋病毒诊断病例增加了24.9%,使其成为艾滋病毒/艾滋病发病率上升的唯一七国集团国家。 Despite this, Canada has seen a 24.9% increase in new HIV diagnoses in 2022 over 2021, making it the only G7 country with a rising HIV/AIDS rate. 研究报告强调,各国政府必须执行这些战略,以实现无艾滋病毒一代人的目标。 The study emphasizes the importance of governments implementing these strategies to reach the goal of an HIV-free generation.